Researchers
Ružić, Dušan
Results 41-60 of 92
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2021 | Epigenetic drug discovery: Successful examples of Computer-Aided Drug Designing of Histone Deacetylase (HDAC6 and SIRT2) and Histone Methyltransferase (DOT1L) inhibitors![]() | Ruzic, Dušan | Conference Paper | Mp. category will be shown later |
| 2021 | Fragment-Based Drug Design of Selective HDAC6 Inhibitors![]() | Ružić, PhD, Dušan | Book parts | Mp. category will be shown later |
| 2021 | An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main Protease | Đoković, Nemanja | Article | 21M21 |
| 2021 | Medicinal chemistry of histone deacetylase inhibitors | Ružić, Dušan | Article | 52M52 |
| 2021 | RATIONAL DESIGN, SYNTHESIS AND IN VITRO TESTING OF - SELECTIVE HDAC6 AND SIRT2 INHIBITORS![]() | Dusan Ruzic | Conference Paper | Mp. category will be shown later |
| 2021 | Application of Computational Methods for Antipsychotic Drug Design and Optimization | Radan, Milica | Conference Paper | Mp. category will be shown later |
| 2021 | Novel 1-benzhydryl piperazine derivative inhibits the migration and invasiveness of breast cancer cells: Synthesis, molecular modelling and biological characterization![]() | Ružić, Dušan | Conference Paper | Mp. category will be shown later |
| 2021 | Synthesis, molecular modelling and biological characterization of novel antimigratory and antiinvasive 1-benzhydryl piperazine derivatives![]() | Dusan Ruzic | Conference Paper | Mp. category will be shown later |
| 2020 | In silico rational drug design and modelling studies of novel 5-HT2A receptor antagonists | Radan, Milica M. | Conference Paper | Mp. category will be shown later |
| 2020 | In silico Identification of Novel 5-HT2A Antagonists Supported with Ligand- and Target- Based Drug Design Methodologies | Radan, Milica | Article | 21M21 |
| 2020 | Discovery of new 5-HT2A receptor antagonists with a strategy of combining ligand and target-based drug design methodologies | Radan, Milica M. | Conference Paper | Mp. category will be shown later |
| 2020 | COST Action 17104 (STRATAGEM), WG2 Meeting and International Online Symposium on: Multitargeting epi-epi drugs for multidrug resistance | Adam Lee; A. Ganesan; I. Bulut; Ceyda Açılan Ayhan; Ružić, Dušan B. | Conference Paper | Mp. category will be shown later |
| 2020 | In silico rational druga design and modelling studies of novel 5-HT2A receptor antagonsts | Radan, Milica | Conference Paper | Mp. category will be shown later |
| 2020 | In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs | Gagić, Žarko | Article | 21M21 |
| 2020 | Combined ligand-based and structure-based approaches in rational drug design of novel 5-HT2A receptor antagonists | Radan, Milica M. | Conference Paper | Mp. category will be shown later |
| 2020 | Multitargeting epi-epi drugs for multidrug reistance | Lee, Adam; Ganesan, A.; Bulut, İpek; Açılan Ayhan, Ceyda; Ružić, Dušan | Conference Paper | Mp. category will be shown later |
| 2019 | Is there a borderline between cytotoxic and antimetastatic effects of selective Histone deacetylase 6 inhibitors in solid malignancies?![]() | Nikolić, Katarina M. | Conference Paper | Mp. category will be shown later |
| 2019 | Structure and ligand based drug design strategies in the development of novel serotonin 5-HT2A receptor antagonists | Radan, Milica M. | Conference Paper | Mp. category will be shown later |
| 2019 | Combined Ligand and Fragment-based Drug Design of Selective Histone Deacetylase-6 Inhibitors | Ružić, Dušan | Article | 21M21 |
| 2019 | Development and Screening of Novel Chemical Probes Targeting Histone Methyltransferase | Si, Yang; Bon, Corentin; Ružić, Dušan | Conference Paper | Mp. category will be shown later |
